Ecosystem News Sree Batchu 8/5/21 Ecosystem News Sree Batchu 8/5/21 Gilead's Kite, Appia Bio to Collaborate on Allogeneic Cell Therapies for Cancer >GILD Read More Industry News Sree Batchu 3/8/21 Industry News Sree Batchu 3/8/21 FDA Approves Gilead/Kite's Yescarta as First CAR-T for Follicular Lymphoma Read More Industry News Guest User 12/9/20 Industry News Guest User 12/9/20 Gilead Announces Racial Equity Community Impact Fund to Support Black Communities Across United States Read More Ecosystem News Guest User 9/14/20 Ecosystem News Guest User 9/14/20 Gilead Moves Deeper into Oncology with $21 Billion Acquisition of Immunomedics Read More
Ecosystem News Sree Batchu 8/5/21 Ecosystem News Sree Batchu 8/5/21 Gilead's Kite, Appia Bio to Collaborate on Allogeneic Cell Therapies for Cancer >GILD Read More
Industry News Sree Batchu 3/8/21 Industry News Sree Batchu 3/8/21 FDA Approves Gilead/Kite's Yescarta as First CAR-T for Follicular Lymphoma Read More
Industry News Guest User 12/9/20 Industry News Guest User 12/9/20 Gilead Announces Racial Equity Community Impact Fund to Support Black Communities Across United States Read More
Ecosystem News Guest User 9/14/20 Ecosystem News Guest User 9/14/20 Gilead Moves Deeper into Oncology with $21 Billion Acquisition of Immunomedics Read More
